SCHEMBL7042389

SCHEMBL7042389

CC(N)(c1ccccc1)c1cccc2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.42
TSHR P16473 3/20 0.40
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 2/20 0.40
HSD17B10 Q99714 4/20 0.40
HPGD P15428 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
HIF1A Q16665 1/20 0.40
ALDH1A1 P00352 4/20 0.39
CYP2A6 P11509 2/20 0.39
KEAP1 Q14145 1/20 0.39
ACP3 P15309 1/20 0.38
KCNN4 O15554 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
TAAR1 Q96RJ0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7587844 0.82 CASR (0.38) TSHRCYP3A4HSD17B10HPGDCYP1A2
SCHEMBL5008800 0.81 TSHR (0.40) KIF11TSHRCYP2C19CYP3A4HSD17B10
SCHEMBL28381882 0.80 KCNN4 (0.53) KIF11TSHRCYP2C19CYP3A4HSD17B10
SCHEMBL5013862 0.80 TSHR (0.42) KIF11TSHRCYP2C19CYP3A4HSD17B10
SCHEMBL3003485 0.80 CYP3A4 (0.42) KIF11TSHRCYP2C19CYP3A4HSD17B10
SCHEMBL1321899 0.79 ALDH1A1 (0.44) KIF11TSHRCYP2C19CYP3A4HSD17B10
SCHEMBL3681420 0.79 ALDH1A1 (0.44) KIF11TSHRCYP2C19CYP3A4HSD17B10
SCHEMBL30344974 0.79 ALDH1A1 (0.44) KIF11TSHRCYP2C19CYP3A4HSD17B10
Hydrochloric Acid SCHEMBL16653113 0.78 ALDH1A1 (0.43) KIF11TSHRCYP3A4HSD17B10HPGD
Hydrochloric Acid SCHEMBL12614790 0.78 ALDH1A1 (0.43) KIF11TSHRCYP3A4HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0659737-B1 Catecholamine surrogates useful as beta 3 agonists BRISTOL MYERS SQUIBB CO (US) 2003-03-26 EP disclosed
US-5776983-A ANTIDIABETIC AGENTS, OBESITY, GASTROINTESTINAL DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-07-07 US disclosed
CN-1109050-A Catecholamine surrogates useful as beta3 agonists BRISTOL MYERS SQUIBB CO (US) 1995-09-27 CN disclosed
EP-0659737-A2 Catecholamine surrogates useful as B3 agonists BRISTOL-MYERS SQUIBB COMPANY (US) 1995-06-28 EP disclosed